glp-1 for ckd Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations | Diabetes Therapy glp-1 and kidney disease glp-1

A recent review in the Journal of Clinical Investigation summarized data showing that GLP-1based drugs reduce key inflammatory mediators and alter innate and adaptive immune responses across multiple organ systems

Br J Pharmacol (2013) 169:33752

Medications like Mounjaro and Zepbound are also gaining popularity, utilizing a mechanism that combines GLP-1 with another hormone and may ultimately prove even more effective

There are also a number studies supporting a role for ghrelin in alcohol craving in humans (Addolorato et al., 2012

[17] What patients should know: If you experience new or worsening anxiety or panic attacks after starting Ozempic, it is essential to discuss this with your healthcare provider